10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
ABBOTT LABORATORIES | ||
Ticker: ABT Fiscal Year: 2022 | ||
Consolidated Balance Sheet | ||
Period Ending Dec 31, 2022 10-K (Filed: Feb 17, 2023) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2022 | Dec 31, 2021 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $ 9,882 | 9,799 |
| Investments, primarily bank time deposits and U.S. treasury bills | 288 | 450 |
| Trade receivables, less allowances of 2022: $500; 2021: $519 | 6,218 | 6,487 |
| Inventories: | ||
| Finished products | 3,805 | 3,081 |
| Work in process | 680 | 694 |
| Materials | 1,688 | 1,382 |
| Total inventories | 6,173 | 5,157 |
| Other prepaid expenses and receivables | 2,663 | 2,346 |
| Total current assets | 25,224 | 24,239 |
| Investments | 766 | 816 |
| Property and equipment, at cost: | ||
| Land | 511 | 525 |
| Buildings | 4,053 | 4,007 |
| Equipment | 14,164 | 13,528 |
| Construction in progress | 1,484 | 1,304 |
| Property and equipment, at cost | 20,212 | 19,364 |
| Less: accumulated depreciation and amortization | 11,050 | 10,405 |
| Net property and equipment | 9,162 | 8,959 |
| Intangible assets, net of amortization | 10,454 | 12,739 |
| Goodwill | 22,799 | 23,231 |
| Deferred income taxes and other assets | 6,033 | 5,212 |
| Total Assets | 74,438 | 75,196 |
| Liabilities and Shareholders Investment | ||
| Current liabilities: | ||
| Trade accounts payable | 4,607 | 4,408 |
| Salaries, wages and commissions | 1,556 | 1,625 |
| Other accrued liabilities | 5,845 | 5,181 |
| Dividends payable | 887 | 831 |
| Income taxes payable | 343 | 306 |
| Current portion of long-term debt | 2,251 | 754 |
| Total current liabilities | 15,489 | 13,105 |
| Long-term debt | 14,522 | 17,296 |
| Post-employment obligations and other long-term liabilities | 7,522 | 8,771 |
| Commitments and contingencies | ||
| Shareholders investment: | ||
| Preferred shares, one dollar par value Authorized 1,000,000 shares, none issued | 0 | 0 |
| Common shares, without par value Authorized 2,400,000,000 shares Issued at stated capital amount Shares: 2022: 1,986,519,278; 2021: 1,985,273,421 | 24,709 | 24,470 |
| Common shares held in treasury, at cost Shares: 2022: 248,724,257; 2021: 221,191,228 | (15,229) | (11,822) |
| Earnings employed in the business | 35,257 | 31,528 |
| Accumulated other comprehensive income (loss) | (8,051) | (8,374) |
| Total Abbott Shareholders Investment | 36,686 | 35,802 |
| Noncontrolling interests in subsidiaries | 219 | 222 |
| Total Shareholders Investment | 36,905 | 36,024 |
| Total Liabilities and Shareholders' Investment | 74,438 | 75,196 |
| External Links | |
| ABBOTT LABORATORIES (ABT) Fiscal Year 2022 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |